Elsevier

Atherosclerosis

Volume 252, September 2016, Pages 207-274
Atherosclerosis

EAS updates
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

https://doi.org/10.1016/j.atherosclerosis.2016.05.037Get rights and content

Keywords

Guidelines
Blood pressure
Clinical settings
Diabetes
Healthy lifestyle
Lipid
Nutrition
Physical activity
Population
Prevention
Primary care
Psychosocial factors
Rehabilitation
Risk assessment
Risk management
Smoking
Stakeholder

Cited by (0)

Additional Contributor: Simone Binno (Italy)

ESC Committee for Practice Guidelines (CPG) and National Cardiac Societies document reviewers: listed in the Appendix.

ESC entities having participated in the development of this document:

Associations: European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA).

Councils: Council on Cardiovascular Nursing and Allied Professions, Council for Cardiology Practice, Council on Cardiovascular Primary Care.

Working Groups: Cardiovascular Pharmacotherapy

The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC.

Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Document Reviewers: Guy De Backer (CPG Review Coordinator) (Belgium), Marco Roffi (CPG Review Coordinator) (Switzerland), Victor Aboyans (France)1, Norbert Bachl (Austria)8, Héctor Bueno (Spain)1, Scipione Carerj (Italy)1, Leslie Cho (USA)1, John Cox (Ireland)10, Johan De Sutter (Belgium)1, Günther Egidi (Germany)1, Miles Fisher (UK)2, Donna Fitzsimons (UK)1, Oscar H. Franco (The Netherlands)1, Maxime Guenoun (France)1, Catriona Jennings (UK)1, Borut Jug (Slovenia)4, Paulus Kirchhof (UK/Germany)1, Kornelia Kotseva (UK)1, Gregory Y.H. Lip (UK)1, François Mach (Switzerland)1, Giuseppe Mancia (Italy)5, Franz Martin Bermudo (Spain)7, Alessandro Mezzani (Italy)1, Alexander Niessner (Austria)1, Piotr Ponikowski (Poland)1, Bernhard Rauch (Germany)1, Lars Rydén (Sweden)1, Adrienne Stauder (Hungary)9, Guillaume Turc (France)6, Olov Wiklund (Sweden)3, Stephan Windecker (Switzerland)1, Jose Luis Zamorano (Spain)1

The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines.

View Abstract